Marta Ruiz‐Riol

Instituto de Salud Carlos III — Spain

Immunology and Microbiology · Life Sciences

14h-index690citations33works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(24), Immune Cell Function and Interaction(12), HIV/AIDS Research and Interventions(10), HIV/AIDS drug development and treatment(8), T-cell and B-cell Immunology(7)

Publications32 total

Long-term neurocognitive outcomes of SARS-CoV-2 infection in a hamster model
Frontiers in Microbiology·2025· 1 citedOpen Access
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
EBioMedicine·2023· 8 citedOpen Access
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
Communications Biology·2023· 22 citedOpen Access
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction
Journal of Virology·2023· 12 citedOpen Access
Disruption of the HLA-E/NKG2X axis is associated with uncontrolled HIV infections
Frontiers in Immunology·2022· 17 citedOpen Access
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
2022· 1 citedOpen Access
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
Nature Medicine·2022· 68 citedOpen Access
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
Frontiers in Immunology·2022· 5 citedOpen Access
T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG
Frontiers in Immunology·2022· 5 citedOpen Access
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Microbiome·2022· 54 citedOpen Access
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
EBioMedicine·2022· 14 citedOpen Access
Additional file 4 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Figshare·2022Open Access
Additional file 3 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Figshare·2022Open Access
Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia Control
2021· 9 citedOpen Access
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent
Journal of Antimicrobial Chemotherapy·2020· 2 citedOpen Access
TL1A–DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1–Specific T Cell Responses
The Journal of Immunology·2020· 3 citedOpen Access
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
PLoS Pathogens·2020· 34 citedOpen Access
In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial
Frontiers in Immunology·2020· 30 citedOpen Access
Can we Just Kick-And-Kill Hiv: Possible Challenges Posed by the Epigenetically Controlled Interplay between Hiv and Host Immunity
Immunotherapy·2019· 10 citedOpen Access
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers
Journal of Virology·2018· 41 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Christian Brander(26), Beatriz Mothe(21), Bonaventura Clotet(16), Javier Martínez‐Picado(13), Anuska Llano(12), Bruna Oriol-Tordera(12), Roger Paredes(10), José Moltó(10), Míriam Rosás-Umbert(8), María C. Puertas(8), Clara Duran-Castells(8), Christian Manzardo(7), Àlex Olvera(7), María Casadellà(6), Marc Noguera-Julián(6), Ricardo Pujol‐Borrell(6), Mariona Parera(5), Michael Meulbroek(5), Francesc Català‐Moll(5), Jorge Sánchez(5)